AI assistant
Sending…
BICYCLE THERAPEUTICS PLC — Director's Dealing 2020
Jan 6, 2020
32777_dirs_2020-01-06_ce979542-eef3-42cd-b05a-020e00a51f14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2019-09-26
Reporting Person: Crockett Nigel (Chief Business Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-09-26 | Employee Stock Option (Right to Buy) | $11.66 | A | 107417 | Acquired | 2029-09-26 | Ordinary Shares (107417) | Direct |
Footnotes
F1: The number of options granted on September 26, 2019 was incorrectly listed as 152,174 on the original Form 4. This amendment is being filed to correct the inadvertent error.
F2: 25% of the shares underlying this option shall vest on September 26, 2020, and the remaining shall vest in 36 equal monthly installments.
More from BICYCLE THERAPEUTICS PLC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 17
Board/Management Information
2026
Mar 17
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 4
Board/Management Information
2026
Feb 3